Literature DB >> 20690031

Alpha-synuclein aggregation is involved in the toxicity induced by ferric iron to SK-N-SH neuroblastoma cells.

Qing He1, Ning Song, Huamin Xu, Rong Wang, Junxia Xie, Hong Jiang.   

Abstract

Increased nigral iron levels and intracytoplasmic Lewy bodies (LBs) in the degenerating neurons are found in Parkinson's disease (PD). Whether LBs formation is involved in the toxicity of iron is largely unknown. In the present study, we observed that the toxicity of ferric iron was enhanced when SK-N-SH cells were overexpressed with wild-type alpha-synuclein. The mitochondrial transmembrane potential (Δψ(m)) and cell viability were decreased in these cells, while the intracellular reactive oxygen species (ROS) were increased, compared with that of control. More aggregated alpha-synuclein was observed in these cells. However, while silencing the expression of alpha-synuclein in SK-N-SH cells with siRNA, iron-induced toxicity could be partially alleviated, indicated by the returned Δψ(m) and cell viability and reduced ROS formation compared with that of control. No alpha-synuclein aggregation could be observed in these cells. The results suggest that alpha-synuclein aggregation was involved in the toxicity of iron to SK-N-SH neuroblastoma cells. Targeting the aggregation of alpha-synuclein might provide a therapeutic strategy for PD in the future.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20690031     DOI: 10.1007/s00702-010-0453-0

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  40 in total

Review 1.  Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.

Authors:  M Goedert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

2.  The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity.

Authors:  N Ostrerova-Golts; L Petrucelli; J Hardy; J M Lee; M Farer; B Wolozin
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

3.  Metal-catalyzed oxidation of alpha-synuclein: helping to define the relationship between oligomers, protofibrils, and filaments.

Authors:  Nelson B Cole; Diane D Murphy; Jacob Lebowitz; Luca Di Noto; Rodney L Levine; Robert L Nussbaum
Journal:  J Biol Chem       Date:  2004-12-21       Impact factor: 5.157

4.  Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.

Authors:  Shunit Gal; Hailin Zheng; Mati Fridkin; Moussa B H Youdim
Journal:  J Neurochem       Date:  2005-10       Impact factor: 5.372

5.  alpha-Synuclein shares physical and functional homology with 14-3-3 proteins.

Authors:  N Ostrerova; L Petrucelli; M Farrer; N Mehta; P Choi; J Hardy; B Wolozin
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

6.  Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine.

Authors:  Eunsung Junn; M Maral Mouradian
Journal:  Neurosci Lett       Date:  2002-03-08       Impact factor: 3.046

7.  Dopamine release rather than content in the caudate putamen is associated with behavioral changes in the iron rat model of Parkinson's disease.

Authors:  Xie Junxia; Jiang Hong; Chen Wenfang; QianZhong Ming
Journal:  Exp Neurol       Date:  2003-08       Impact factor: 5.330

8.  Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis.

Authors:  E C Hirsch; J P Brandel; P Galle; F Javoy-Agid; Y Agid
Journal:  J Neurochem       Date:  1991-02       Impact factor: 5.372

9.  Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells.

Authors:  Shuzhen Zhang; Jun Wang; Ning Song; Junxia Xie; Hong Jiang
Journal:  Neurobiol Aging       Date:  2008-01-08       Impact factor: 4.673

10.  Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers.

Authors:  Marcus Kostka; Tobias Högen; Karin M Danzer; Johannes Levin; Matthias Habeck; Andreas Wirth; Richard Wagner; Charles G Glabe; Sabine Finger; Udo Heinzelmann; Patrick Garidel; Wenzhen Duan; Christopher A Ross; Hans Kretzschmar; Armin Giese
Journal:  J Biol Chem       Date:  2008-02-07       Impact factor: 5.157

View more
  13 in total

1.  Superficial siderosis associated with abundant τ and α-synuclein accumulation.

Authors:  Masaki Takao; Shigeo Murayama; Youji Yoshida; Ban Mihara
Journal:  BMJ Case Rep       Date:  2011-12-01

2.  α-Synuclein Over-Expression Induces Increased Iron Accumulation and Redistribution in Iron-Exposed Neurons.

Authors:  Richard Ortega; Asuncion Carmona; Stéphane Roudeau; Laura Perrin; Tanja Dučić; Eleonora Carboni; Sylvain Bohic; Peter Cloetens; Paul Lingor
Journal:  Mol Neurobiol       Date:  2015-04-02       Impact factor: 5.590

3.  Individual Amino Acid Supplementation Can Improve Energy Metabolism and Decrease ROS Production in Neuronal Cells Overexpressing Alpha-Synuclein.

Authors:  Vedad Delic; Jeddidiah W D Griffin; Sandra Zivkovic; Yumeng Zhang; Tam-Anh Phan; Henry Gong; Dale Chaput; Christian Reynes; Vinh B Dinh; Josean Cruz; Eni Cvitkovic; Devon Placides; Ernide Frederic; Hamed Mirzaei; Stanley M Stevens; Umesh Jinwal; Daniel C Lee; Patrick C Bradshaw
Journal:  Neuromolecular Med       Date:  2017-06-15       Impact factor: 3.843

4.  Cardiac Light Chain Amyloidosis: The Role of Metal Ions in Oxidative Stress and Mitochondrial Damage.

Authors:  Luisa Diomede; Margherita Romeo; Paola Rognoni; Marten Beeg; Claudia Foray; Elena Ghibaudi; Giovanni Palladini; Robert A Cherny; Laura Verga; Gian Luca Capello; Vittorio Perfetti; Fabio Fiordaliso; Giampaolo Merlini; Mario Salmona
Journal:  Antioxid Redox Signal       Date:  2017-03-03       Impact factor: 8.401

5.  Expanded and Wild-type Ataxin-3 Modify the Redox Status of SH-SY5Y Cells Overexpressing α-Synuclein.

Authors:  Carolina Noronha; Rita Perfeito; Mário Laço; Ullrich Wüllner; A Cristina Rego
Journal:  Neurochem Res       Date:  2017-02-25       Impact factor: 3.996

6.  Acetylcholinesterase-independent protective effects of huperzine A against iron overload-induced oxidative damage and aberrant iron metabolism signaling in rat cortical neurons.

Authors:  Ling-Xue Tao; Xiao-Tian Huang; Yu-Ting Chen; Xi-Can Tang; Hai-Yan Zhang
Journal:  Acta Pharmacol Sin       Date:  2016-08-08       Impact factor: 6.150

7.  Overdosing on iron: Elevated iron and degenerative brain disorders.

Authors:  Santosh R D'Mello; Mark C Kindy
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

8.  Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.

Authors:  Naying He; Huawei Ling; Bei Ding; Juan Huang; Yong Zhang; Zhongping Zhang; Chunlei Liu; Kemin Chen; Fuhua Yan
Journal:  Hum Brain Mapp       Date:  2015-08-07       Impact factor: 5.038

9.  The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease.

Authors:  David I Finkelstein; Jessica L Billings; Paul A Adlard; Scott Ayton; Amelia Sedjahtera; Colin L Masters; Simon Wilkins; David M Shackleford; Susan A Charman; Wojciech Bal; Izabela A Zawisza; Ewa Kurowska; Andrew L Gundlach; Sheri Ma; Ashley I Bush; Dominic J Hare; Philip A Doble; Simon Crawford; Elisabeth Cl Gautier; Jack Parsons; Penny Huggins; Kevin J Barnham; Robert A Cherny
Journal:  Acta Neuropathol Commun       Date:  2017-06-28       Impact factor: 7.801

Review 10.  Nigral iron elevation is an invariable feature of Parkinson's disease and is a sufficient cause of neurodegeneration.

Authors:  Scott Ayton; Peng Lei
Journal:  Biomed Res Int       Date:  2014-01-16       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.